Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Veterans Affairs was posted on September 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Prednisolone 1% Ophthalmic Solution

Closed
36E79726R0037Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs, through the OPAL Enterprise Procurement Office, is soliciting offers for the procurement of Prednisolone Acetate 1% Ophthalmic Suspension. This unrestricted procurement is designated as a HUBZONE Small Business set-aside and aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Supplies will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs, with requirements for three package sizes: 5ml, 10ml, and 15ml bottles. Award will be made to a single responsible offeror for all line items based on the Lowest Price Technically Acceptable (LPTA) approach. To be considered technically acceptable, offerors must provide FDA-approved pharmaceuticals with unique 11-digit NDC numbers and demonstrate that manufacturing facilities are FDA cGMP acceptable. Strict packaging and labeling standards are required, including GS1-128 or HIBC linear bar codes and 2D data matrix bar codes per the Drug Supply Chain Security Act. Proposals must be submitted by October 14, 2026, and must include a signed SF-1449, a 0.5% cost recovery fee in the pricing, and a letter of commitment from the manufacturer if the offeror is not the producer.

General Info

HUBZONE set-aside for Prednisolone Acetate 1% Ophthalmic Suspension via LPTA award process.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

2
DOCX, High priority: read this firstrfp
High
DOCX, Low prioritypresolicitation
Low

Read all 2 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Supply of Ringer's Injection, LactatedOpen now, due in 6 days
  • Sodium Chloride Injection SupplierOpen now, due in 6 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts

Full Description

Show more
N/A

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Nitroglycerin Patches
Solicitation # 36E79727R0010
The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

7 days ago

DEADLINE

in 1 day
View Details
NAICS: 325412
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Pharmaceutical Preparation Manufacturing

POSTED

18 days ago

DEADLINE

in about 1 hour
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS